Prospective, longitudinal cohort study of follow-up in patients with COVID-19 infection and requiring inpatient treatment for respiratory disease

Prospective, longitudinal cohort study of follow-up in patients with COVID-19 infection and requiring inpatient treatment for respiratory disease - COVAS

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00027106

Enrollment

1000

Registered

2021-11-05

Start date

2020-08-28

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

Group 1: The demographic and biometric data of patient with COVID-19 are collected and a medical history is taken. During the anamnesis, typical symptoms and risk factors of the COVID-19 infection are

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age of majority Written declaration of consent Persons who are legally competent and mentally able to able to follow the instructions of the study staff.

Exclusion criteria

Exclusion criteria: Younger than 18 years (20 years for Japanese nationality) Pregnant and breastfeeding women (will be asked) Immobility with need for care Lack of maturity

Design outcomes

Primary

Measure	Time frame
Time till development of ARDS	—

Secondary

Measure	Time frame
Pulmonary-related mortality Duration of ventilation and hospitalisation for COVID-19 Time to ventilation Time to sepsis Time to non-cardiac death Time to all-cause mortality Time to non-fatal terminal renal failure renal failure Time to development of heart failure (HFrEF)	—

Countries

Germany

Contacts

Public ContactMarlo Verket

Med. Klinik I, Uniklinikum RWTH Aachen

mverket@ukaachen.de+492418038067

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026